Olema Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Comprehensive Sustainability assessment of Olema Pharmaceuticals Inc can be reached by registering for free. The report of Olema Pharmaceuticals Inc incorporates data points from across the internet as well as from public filings by Olema Pharmaceuticals Inc. This Disclosure score covers 17 UN Sustainable Development Goals including: 'Affordable & Clean Energy', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'.
Olema Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 3.2, social score of 4.8 and governance score of 6.7.
5.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 958 | Provectus Biopharmaceuticals Inc | 5.2 | High |
| 958 | Vectura Group Services Ltd | 5.2 | High |
| 999 | Olema Pharmaceuticals Inc | 5.1 | High |
| 999 | Aequus Pharmaceuticals Inc | 5.1 | High |
| 999 | BioRestorative Therapies Inc | 5.1 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Olema Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Olema Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Olema Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Olema Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Olema Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Olema Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Olema Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Olema Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.